U.S. medical industry complex spending its market subsidies

Summary:Doctors are the gatekeepers to the U.S. market, not insurers and not the government. So drug and device makers get a full retail mark-up here, without the haggling over price and efficacy that are common in Europe.

All the money we waste on drugs and medical devices does go somewhere.

Mostly it goes to drug companies and device makers. The U.S. market is very, very friendly for these folks. Once they get FDA approval they don't have to convince a government that theirs is the best treatment, or better than other treatments.

They just go out and sell.

Doctors are the gatekeepers to the U.S. market, not insurers and not the government. So drug and device makers get a full retail mark-up here, without the haggling over price and efficacy that are common in Europe.

This has acted as a subsidy to U.S. drug and device makers, an enormous subsidy they are now spending:

The action is not all one-way. U.S. companies are also worth buying thanks to the good deal they get at home. That's why Sepracor, which makes inhalants, was bought recently by a unit of Japan's Sumitomo. Nearly $160 billion in health care related deals have been done this year, mostly in the drug area.

UPDATE: Covidien, which is based in Ireland, also agreed today to buy Aspect Medical of Massachusetts, which makes brain monitoring systems, for $210 million.

This is the flip side of health reform. Any effort to push down health care costs could cost these companies money and power. This is what Betsy McCaughey was talking about early this year when she charged health reform treats health reform as "a cost problem instead of a growth industry.”

It is a growth industry. And you're behind the growth. The question is whether you can afford to continue being so generous. The industry's merger frenzy suggests the answer is no.

This post was originally published on Smartplanet.com

Topics: Innovation

About

Dana Blankenhorn has been a business journalist since 1978, and has covered technology since 1982. He launched the Interactive Age Daily, the first daily coverage of the Internet to launch with a magazine, in September 1994.

zdnet_core.socialButton.googleLabel Contact Disclosure

Kick off your day with ZDNet's daily email newsletter. It's the freshest tech news and opinion, served hot. Get it.

Related Stories

The best of ZDNet, delivered

You have been successfully signed up. To sign up for more newsletters or to manage your account, visit the Newsletter Subscription Center.
Subscription failed.